Loading
Cardiovascular Disease and Adiposity / Extracellular Vesicles in Disease / Liver Disease Diagnosis and Treatment · Journal article
Scientific Reports · August 15, 2026
Raises a question worth testing. It does not answer one.
This is an in vitro proof-of-concept study demonstrating that adipocyte-derived extracellular vesicles show differential composition and metabolic effects on hepatocytes depending on whether the source adipocytes were cultured under normoglycemic or hyperglycemic conditions. EVs from hyperglycemic adipocytes carried higher FABP4 and promoted lipid accumulation in hepatocytes, while normoglycemic EVs contained more adiponectin and were associated with reduced lipid accumulation. The work proposes a cellular model for studying adipose-liver cross-talk but provides no clinical or in vivo evidence.
In vitro experimental study. Differentiated adipocytes and hepatocytes cultured in vitro under two glucose conditions.. Intervention: Extracellular vesicles derived from adipocytes cultured under hyperglycemic conditions. Compared with: Extracellular vesicles derived from adipocytes cultured under normoglycemic conditions.
EVs derived under normoglycemic conditions contained higher levels of adiponectin and showed gene expression patterns indicative of reduced lipid accumulation in hepatocytes EVs derived under hyperglycemic conditions exhibited higher FABP4 levels and were associated with increased lipid accumulation in hepatocytes Metabolic state of adipocytes reshapes the biomolecular composition of EVs, which is associated with differential metabolic responses in hepatocytes
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This is a mechanistic study with no direct clinical application at present. It may inform future investigation of EV-mediated adipose-liver signaling in MASLD but does not provide evidence to guide clinical practice or drug development.
In vitro mechanistic study establishing an exploratory model of adipose-liver communication via extracellular vesicles; raises questions about EV-mediated metabolic signaling but does not measure clinical outcomes or hard endpoints.
As stated by the source record.
This is a mechanistic study with no direct clinical application at present. It may inform future investigation of EV-mediated adipose-liver signaling in MASLD but does not provide evidence to guide clinical practice or drug development.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the most prevalent chronic liver disorders and is closely linked to obesity, insulin resistance, and type 2 diabetes mellitus. Recent studies have reported that extracellular vesicles (EVs) secreted from adipose tissue play a pivotal role in the onset and progression of MASLD. In this study, we aimed to establish an adipocyte-derived EV-based in vitro model to investigate adipose tissue–liver metabolic communication associated with MASLD. EVs were isolated from adipocytes differentiated under normoglycemic and diabetic-like hyperglycemic conditions and subsequently applied to hepatocytes. EVs derived under normoglycemic conditions contained higher levels of adiponectin and were associated with gene expression patterns indicative of reduced lipid accumulation. In contrast, EVs derived under hyperglycemic conditions exhibited higher FABP4 levels and were associated with increased lipid accumulation in hepatocytes. These findings indicate that the metabolic state of adipocytes reshapes the biomolecular composition of EVs, which is associated with differential metabolic responses in hepatocytes. Collectively, our results support the potential utility of adipocyte-derived EVs as an in vitro platform for studying adipose tissue–liver metabolic communication associated with MASLD and highlight the importance of EV-mediated communication between adipose tissue and the liver.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.